ALLURION TECHNOLOGIES, INC.
Close on Oct 19, 2026
- Market cap
- $6.34M
- P/E (TTM)
- –
- Dividend yield
- –
About Allurion Technologies
Surgical & Medical Instruments & Apparatus, SIC 3841
The provided excerpt consists exclusively of raw XBRL taxonomies, accounting identifiers, and financial schedule tags rather than descriptive business disclosures. As a result, the provided text does not contain factual information regarding the company's business activities, products, services, operating segments, or customer types.
Similarly, the supplied text does not include narrative details regarding operational scale, geographic locations, store counts, or corporate headquarters. Because the description must rely strictly and solely on the provided text, no operational or geographic profile can be stated.
Summary of the business section of Allurion Technologies's latest annual report, written by StockData.
Company profile
Company
- Legal name
- ALLURION TECHNOLOGIES, INC.
- Headquarters
- Natick, MA
- Address
- 11 Huron Dr Ste 200 01760
- Phone
- (508) 647-4000
- Employees
- 41, Dec 31, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Deloitte & Touche LLP, Boston, Massachusetts
Stock & identifiers
- Ticker
- ALUR
- Other tickers
- ALURW
- Exchange
- OTC
- IPO date
- Jun 28, 2024
- Shares outstanding
- 15M, May 12, 2026
- Public float
- $20.67M, Jun 30, 2025
- Filer category
- <br>Emerging growth company
- Stock splits
- 1-for-25 reverse, Mar 27, 2025; 1-for-25 reverse, Jan 3, 2025; 7-for-2, Nov 14, 2023
- SEC CIK
- 1964979
- CUSIP
- 02008G110
- ISIN
- US02008G1105
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Shantanu Gaur | Chief Executive Officer, Director | 37,908 |
| Ojas Buch | Chief Operating Officer | 10,223 |
| Brendan M. Gibbons | Chief Legal Officer | 10,408 |
| Michael R. Davin | Director | 4,418 |
| Innovation Master Fund Ltd. RTW | Director | 202,096 |
| Rtw Master Fund, Ltd. | Director | – |
| Robert Jason Richey | Director | – |
| Keith B. Johns II | Director | 326,086 |
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had 41 employees, 38 of whom were full-time, consisting of clinical, research and development, operations, regulatory and quality, sales, marketing, technology, finance, business analytics and human resources.”
Corporate history
Events identified from SEC filings